Month: 2025-09

Lac Knife graphite shows 26% higher cathode density in battery test, opening premium market opportunities beyond anodes, and zero-waste potential.Ottawa, Ontario--(ACN Newswire via SeaPRwire.com - September 15, 2025) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company"), a leading Canadian graphite developer advancing high-grade projects in Quebec, is pleased to announce highly encouraging early results from independent battery cell testing conducted by Charge CCCV LLC ("C4V"), a New York-based leader in lithium-ion battery technology and gigafactory design.Initial results demonstrate that spheroidization rejects from the Lac Knife deposit - typically considered waste - produced a twenty-six percent (26%) increase in cathode electrode density in single-side coated electrodes (2.39 g/cc vs. 1.76 g/cc baseline). A total of four percent (4%) conductive additive was used in the lithium iron phosphate ("LFP") cathode, made up of two percent (2%) carbon black and two percent (2%) Lac Knife Cathode (LKC) Ultima (50:50 ratio). The tests also showed equivalent conductivity and comparable cycling stability up to forty (40) cycles. These findings suggest Lac Knife graphite by-products may represent a high-value conductive additive and significant energy-storage advantages with potential to replace or complement carbon black, the industry standard, while enabling a zero-waste processing model.Higher cathode density allows more active material to be packed into each cell, effectively increasing energy storage without enlarging the battery size. This improvement allows battery manufacturers to achieve higher volumetric energy density, better efficiency, and lower cost per kilowatt-hour, all while maintaining the inherent safety and cycle life of LFP cells like C4V's BMLMP (P Series cells) which currently increase voltage and energy density by fifteen percent (15%) compared to typical LFP cells. With this innovation, Focus is enabling the next generation of high-performance, cost-effective lithium-ion batteries - an advantage that is particularly meaningful for Battery Energy Storage Systems (BESS) supporting renewable energy & EV systems. The ability to achieve greater density without sacrificing conductivity or cycling stability underscores the potential value of Lac Knife graphite as a next-generation conductive additive.This opportunity is further reinforced by the rapid growth in the market for lithium-ion battery (LIB) cathode conductive auxiliary agents. According to a January 2025 report by Markets and Markets, the global market is expected to expand from approximately US$1.80 billion in 2024 to US$4.32 billion by 2029, representing a compound annual growth rate (CAGR) of about 19.1%1. With such robust growth forecasts, early evidence that Lac Knife graphite can compete with and potentially outperform conventional carbon black highlights the strategic opportunity for Focus Graphite to participate in a high-value, high-growth specialty market.If validated through larger-scale testing, this breakthrough could enable Focus to fully utilize its concentrate, create high-value by-products, and diversify into cathode markets all while offering ESG advantages through Quebec's renewable hydro energy and a potential clean-energy carbon footprint. The Company plans to advance testing to single pouch cells (150mAh) & multilayer pouch cells (3Ah), explore different blend ratios (e.g. 60/40 or 70/30), and continue joint validation with C4V to assess scalability."These early results validate the potential for Lac Knife graphite to expand beyond anode applications," said Baasit Ali Shaik Sulaiman, VP Supply Chain of C4V. "Often single digit improvements in battery applications are notable. We look forward to advancing this collaboration through larger format batteries as part of our Digital DNA® program and the potential of this product for the North American supply chain.""We continue to showcase the versatility of our Lac Knife deposit," said Dean Hanisch, CEO of Focus Graphite. "A twenty-six percent improvement in cathode density is an encouraging early result in an industry where even small gains matter. Enabled by Lac Knife's unique flake and our use of a thermal fluidized bed oven, these findings suggest that by-products may be transformed into high-value cathode materials with zero-waste potential. While further testing and validation are required, this work indicates possible applications in Battery Energy Storage Systems, one of the fastest-growing segments of the market. This aligns with our strategy to maximize the value of Lac Knife's graphite flakes and advance opportunities to supply premium materials to downstream customers."Figure 1: Cycle Performance Comparison: LKC Ultima Blend vs. C4V Baseline Carbon BlackTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1963/266408_fe817751b4ae59a7_001full.jpgFigure 2: Normalized Cycling Comparison of LKC Ultima Blend vs. C4V Baseline Carbon BlackTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1963/266408_fe817751b4ae59a7_002full.jpgFigure 3: Summary of Cathode Performance Metrics, LKC Ultima Blend vs. C4V Baseline Carbon BlackTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1963/266408_fe817751b4ae59a7_003full.jpgFigure 4: Product Information Bulletin for Lac Knife Cathode (LKC) UltimaTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1963/266408_fe817751b4ae59a7_004full.jpgAbout Charge CCCV (C4V)C4V™ is a lithium-ion battery technology company possessing critical insights related to the optimum performance of lithium-ion batteries and Gigafactory's. C4V's discoveries have been fruitful in vastly extending battery life, safety and charge performance, however more important is the Gigafactory offering that allows emerging countries to establish their own robust manufacturing ecosystem. C4V works with industry-leading raw material suppliers and equipment supply chain to bring to market fully optimized batteries possessing key economic advantages providing the ultimate "best in class" performance for various applications and end- to-end solutions to produce them on a Gigawatt hour scale. With its unique and innovative business model C4V is rapidly gearing towards 100+GWh of cell production capacity globally by 2032 and its Digital DNA Supply Chain solution ensures materials meet the highest industry standards for performance and reliability.For more information on C4V please visit http://www.chargecccv.com.About Focus Graphite Advanced Materials Inc. Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Our flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defense, and advanced materials industries.Our Lac Tetepisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, we go beyond mining - we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency.Our commitment to innovation ensures a chemical-free, eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals - reducing dependence on foreign-controlled markets and driving the transition to a sustainable future.For more information on Focus Graphite Inc. please visit http://www.focusgraphite.comInvestors Contact: Dean HanischCEO, Focus Graphite Inc.dhanisch@focusgraphite.com+1 (613) 612-6060Jason LatkowcerVP Corporate Developmentjlatkowcer@focusgraphite.comCautionary Note Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events.In particular, this press release contains forward-looking information relating to, among other things, the potential applications of Lac Knife graphite by-products as conductive additives in lithium iron phosphate (LFP) cathodes, the significance of the twenty-six percent (26%) improvement in electrode density observed in early testing, and the anticipated benefits of higher cathode density for energy storage systems. It also includes statements regarding the Company's ability to fully utilize its concentrate, create high-value by-products, diversify into cathode markets, and deliver environmental, social, and governance (ESG) advantages through Québec's hydro-powered, low-carbon energy infrastructure. Forward-looking information further includes the Company's plans to advance testing beyond coin cells into pouch cells, to explore alternative blend ratios, and to continue collaboration with Charge CCCV LLC ("C4V") to validate scalability.Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company's public disclosure documents available under its profile on SEDAR+.The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.1 Source: https://www.marketsandmarkets.com/Market-Reports/lib-cathode-conductive-auxiliary-agents-market-54153618.html#:~:text=Overview,USD%201.80%20billion%20in%202024. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/266408 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Sep 15, 2025 - (ACN Newswire via SeaPRwire.com) – Hong Kong’s healthcare sector surged by nearly 30% in the last decade, with the total number of related businesses now exceeding 3,000. Details of this rapid and sustained growth are among the findings of a new study by HKTDC Research, titled “I&T Cooperation in the Guangdong-Hong Kong-Macao Greater Bay Area: Hong Kong Partners with Mainland Cities in Advancing Biomedical Upgrade in the GBA”.This report was produced alongside “Seizing GBA Opportunities: Biomedical Co-operation and Development”, a joint research initiative with the Department of Commerce of Guangdong Province.Overall, the research demonstrates that not only is Hong Kong successfully collaborating with key Guangdong GBA cities and Macao in biomedical innovation, but also that this collective endeavour is on course for sustained growth.The successes to date have also been reflected primarily in the overall increase in the sector's value in regional terms.Hong Kong in step with GBA biomedical partnersJust as Hong Kong has developed a sizable pharmaceutical and medical device cluster over recent years – with 3,020 related companies in 2023 as opposed to 2,340 in 2013 – so, too, has Guangdong looked to develop related resources.Acknowledging the benefits of such a partnership, HKTDC Research Director Irina Fan said: “Thanks to extensive government support, technological innovation has been a key driver of Hong Kong’s economic growth, allowing it to effectively align with the national prioritisation of new quality productive forces. Earlier this year, the Guangdong Government announced action plans to grow its biomedical and healthcare industry cluster by around 50% by 2027, increasing its value from RMB 664 billion in 2023 to more than a trillion. Tellingly, a key element of this plan is to boost development by leveraging the existing strengths of the Hong Kong platform.”“Being able to share this expertise with our partner cities in the GBA, with a particular focus on biomedicals, is a huge opportunity for all concerned and one set to deliver immense benefits nationally and even globally.”Hong Kong: Driving biotech innovationAmong the many advantages global biotech businesses might seek to leverage is the comprehensive array of funding opportunities Hong Kong has access to, thanks to its status as a leading international financial centre.As of June 2025, total market capitalisation of the Hong Kong-listed healthcare sector was US$441 billion – accounting for ~8.1% of the total market cap of Hong Kong-listed companies – which is three times the US$144 billion figure recorded at the end of 2017, pre-dating the launch of the HKEX Chapter 18A regime.Since the Chapter 18A listing rules came into effect – which allows biotech firms without recorded revenue or profits to list – 73 biotech companies have listed, collectively raising US$16 billion as of mid-2025.Expanding on the range of benefits Hong Kong can offer to biotech businesses based in partner GBA cities, Wing Chu, HKTDC Deputy Director of Research (Officer-in-Charge), said: “Beyond its financial resources, Hong Kong has several technical capabilities that will make a real difference to GBA businesses, as they look to expand their activities throughout the mainland and into many of the overseas markets. In particular, the city’s advanced clinical trial services, all of which yield internationally accepted data, make Hong Kong the ideal launchpad for any regional healthcare venture looking to go global.”At present, the clinical data derived through Hong Kong-based trials has been approved for use by many of the world’s leading regulatory bodies, including the US Food and Drug Administration, the EU’s European Medicines Agency and Mainland China’s National Medical Products Administration (NMPA).In addition, many of Hong Kong’s foremost healthcare institutions, including Queen Mary Hospital, Prince of Wales Hospital, Hong Kong Eye Hospital and Hong Kong Sanatorium & Hospital, have secured NMPA accreditation.The GBA: A world-leading biotech innovation hubIn terms of international recognition, the World Intellectual Property Organization designated the Shenzhen-Hong Kong-Guangzhou cluster as the world’s leading innovation hub in its 2025 Global Innovation Index. This, in part at least, was in recognition of the lead role biotechnology plays within this cutting-edge cluster.It is also important to acknowledge the extraordinary growth of Hong Kong’s biotech and health start-up sectors, which have developed far more rapidly than many comparable sectors.Indeed, between 2018 and 2024, the number of Hong Kong-based biotech and healthtech start-ups more than quadrupled from 110 to 510, while the sectors’ share of the city’s total start-up ecosystem rose from 4% to 11%. This included a range of pioneering businesses in sectors, such as drug development, gene editing technology, medical device innovation and precision medical solutions.Outlining how future intra-regional cooperation could benefit all parties, Cherry Yeung, HKTDC Research Senior Economist with oversight of these new reports, said: “Hong Kong is already seamlessly connected with many of the pharmaceutical manufacturers and markets in Mainland China, thanks to its strengths in R&D and international trade. For their part, the GBA cities deliver considerable production as well as resource support, creating a real synergy across the board. With Guangdong committed to further expanding its biomedical sector, this will foster a new generation of cross-industry collaboration.”Photo download: http://bit.ly/4nc0SAcProduction and Trading of Drugs and Medical Supplies (Source: Census and Statistics Department of Hong Kong)Between 2018 and 2024, the number of Hong Kong-based biotech and healthtech start-ups more than quadrupled from 110 to 510, while the sectors’ share of the city’s total start-up ecosystem rose from 4% to 11% (Source: InvestHK)Media enquiriesPlease contact the HKTDC’s Communication and Public Affairs Department:Johnny TsuiTel: (852) 2584 4395Email: johnny.cy.tsui@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年9月15日 - (亞太商訊 via SeaPRwire.com) - 9月10日，由北京市衛生健康委員會主辦的2025中國國際服務貿易交易會（服貿會）健康服務專題創新成果發佈暨啟動活動在北京舉行。柬埔寨王國衛生部國務秘書宋文達（Sung Vinntak）博士率領七人代表團專程出席。活動期間，宋文達國務秘書代表柬埔寨王國衛生部，正式向同仁堂集團遞交北京同仁堂安宮牛黃丸許可證書，同仁堂集團黨委副書記、董事、總經理邸淑兵接收證書。論壇期間，宋文達做主旨發言，他表示作為中醫藥領域的經典急救藥品，安宮牛黃丸進入柬埔寨市場將有效填補當地傳統醫藥急救類產品的市場空白，為柬埔寨民眾應對中風、高熱驚厥等急症提供新的優質選擇，直接助力了當地醫療資源供給升級。他對中柬繼續加強中醫藥合作高度期待，強調此次安宮牛黃丸註冊進展只是雙方合作的起點，柬埔寨衛生部將以此次合作為契機，與中國在傳統醫藥領域展開更深度、更廣泛的協作。雙方已達成共識，未來將在產品註冊、科研合作、藥材貿易及人才培養四大領域持續深化合作：產品註冊方面，推動更多優質中藥產品進入柬埔寨市場；科研合作方面，聯合開展傳統醫藥的臨床研究與學術交流；藥材貿易方面，探索中藥材供應鏈的協同發展；人才培養方面，攜手共建傳統醫藥專業人才培養體系。這一系列合作舉措，將全方位助力柬埔寨傳統醫藥事業發展，也為中柬中醫藥服務貿易合作開闢更廣闊的空間。宋文達在會前接受媒體採訪時進一步表示，同仁堂作為中醫藥在中國境外市場發展的開拓者，在本屆服貿會上展示了一系列亮眼的國際合作成果，彰顯了中國傳統醫藥在全球服務貿易領域的獨特價值。尤其是同仁堂安宮牛黃丸在柬埔寨的正式註冊，更是一個令人興奮的突破。據瞭解，今年是中柬建交67周年，兩國在構建新時代全天候中柬命運共同體框架下，衛生健康領域協作持續深化。今年初，同仁堂集團黨委書記、董事長戴小鋒率團訪問柬埔寨王國衛生部，重點研究同仁堂系列藥品註冊事宜，為推動雙方傳統醫藥合作奠定堅實基礎。本次柬埔寨衛生部代表團回訪同仁堂，核心目標聚焦於推動中柬傳統醫藥合作落地見效，更是中柬鐵杆友誼在衛生健康領域的繼續延伸。隨著雙方合作成果的逐步落地，中柬兩國醫藥文化交流互鑒必將進一步深化，中醫藥這一中華優秀文化瑰寶必將在柬埔寨綻放新光彩，為兩國民眾健康福祉保駕護航。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Sep 15, 2025 - (ACN Newswire via SeaPRwire.com) – The 44th HKTDC Hong Kong Watch & Clock Fair and the 13th Salon de TIME, jointly organised by the Hong Kong Trade Development Council (HKTDC), Hong Kong Watch Manufacturers Association Limited, and The Federation of Hong Kong Watch Trades & Industries Limited, closed their doors on 6 September after attracting some 16,000 trade buyers from 95 countries and regions. One of the highlights of the two fairs was the 42nd Hong Kong Watch and Clock Design Competition with winning and shortlisted entries on display together with an awards ceremony at the event stage.Over the years, the Hong Kong Watch and Clock Design Competition has consistently worked to raise the quality of watch and clock design in Hong Kong by encouraging innovation and creativity. At the same time, by enhancing its exhibition offerings, it aims to boost sales of Hong Kong-made watches and clocks both domestically and internationally.This year’s competition featured an Open Group and a Student Group, themed “Memorable” and “Believe in Yourself”, respectively. “Memorable” invited participants to express their feelings about unforgettable people by capturing those emotions in their watch designs. In contrast, “Believe in Yourself” encouraged designers to showcase confidence, perseverance, and courage in pursuing dreams and achieving goals through their creations.This year's competition received an enthusiastic response, with 116 entries. The judging panel consisted of eight representatives from the watch and clock industry, along with guest judge, celebrity Bowie Cheung, who selected the winners, first and second runners-up, and merit award winners in both groups.Open Group entries break with tradition, offering playful design elementsThe winner of the Open Group is “FREEZE”, designed by Tam Kwok Tung and sponsored by Wincy Horological Ltd. Tam’s design was inspired by his father who always had half of his face covered by the camera when taking pictures for him. The dial centres on a camera lens creating a layout that breaks from tradition. The right window displays the watch’s movement, while the left window features gears which drive the hands.The first runner-up is “RB_ROBO”, designed by Wong Ting Bong and sponsored by Youngs Watch Company Limited and Po Fai Precision Company Limited. Inspired by toy robots, the design conveys the idea that “adults can still preserve their childlike innocence”.The second runner-up, “Backtrack”, was designed by Oro Time Limited. It incorporates elements such as “game consoles”, “VHS tapes”, and “vinyl records”, allowing the watch to become a playful, Y2K-inspired fashion accessory by swapping out different “game cartridges”.Watch Design by student group reflects on elements of successThe Student Group category is open to full-time students registered at schools in Hong Kong and aims to recognise and promote talented young designers through the competition. The winning piece, “Aspire”, was designed by Chan Tsz Ying, who studies at the Hong Kong Design Institute. In this watch, moving beads symbolise courageous and confident goal-chasing, while still beads signify moments of reflection.The first runner-up is Lee Yuet Tung Eudora from Good Hope School. Her creation, “Believe in Yourself”, features the words “Love”, “Hope”, and “Faith” printed on the outer ring of the watch, highlighting these three crucial guides to achieving success and overcoming challenges.The second runner-up, titled “Broken Stars in the Ripples”, was designed by Yip Yuen Sze Christine from the Hong Kong Design Institute. The watch features ripple patterns on its surface and uses a star as the hour hand, conveying the message “Even if life has ups and downs, it is still full of hope”.This year, the Made-to-Sell Award continued to be a part of the event, with a judging panel comprising eight veteran watch manufacturers and Stephen Liang, former Assistant Executive Director of HKTDC. The judges select one work from the Student Group which they consider to have strong market potential. The award was once again won by the winner, Chan Tsz Ying of the Hong Kong Design Institute for her design, “Aspire”. The Hong Kong Watch Manufacturers Association Limited and The Federation of Hong Kong Watch Trades & Industries Limited will put her award-winning design into production and release it for sale at the HKTDC Design Gallery.Photo download: http://bit.ly/4n9MgRQFREEZE: Open Group winner of the 42nd Hong Kong Watch & Clock Design CompetitionRB_ROBO: Open Group first runner-up of the 42nd Hong Kong Watch & Clock Design CompetitionBacktrack: Open Group second runner-up of the 42nd Hong Kong Watch & Clock Design CompetitionAspire: Student Group winner and the Made-to-Sell Award of the 42nd Hong Kong Watch & Clock Design CompetitionBelieve in Yourself: Student Group first runner-up of the 42nd Hong Kong Watch & Clock Design CompetitionBroken Stars in the Ripples: Student Group second runner-up of the 42nd Hong Kong Watch & Clock Design CompetitionThe 42nd Hong Kong Watch & Clock Design Competition featured Open Group and Student Group category winners. Celebrity guest judge Bowie Cheung attended the award ceremony.WebsitesHong Kong Watch & Clock Fair: hkwatchfair.hktdc.comSalon de TIME: https://www.hktdc.com/event/te/enMedia enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department:Johnny Tsui Tel: (852) 2584 4395 Email: johnny.cy.tsui@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年9月15日 - (亞太商訊 via SeaPRwire.com) - 由香港貿易發展局（香港貿發局）、香港表廠商會有限公司及香港鐘表業總會有限公司合辦的第44屆香港貿發局香港鐘表展及第13屆國際名表薈萃，實體展於9月6日結束，合共吸引約16,000名、來自95國家及地區的商貿買家到場採購。至於由香港貿發局聯同香港表廠商會有限公司及香港鐘表業總會有限公司合辦的第42屆香港鐘表設計比賽，賽果已正式揭曉，所有獲獎及入圍作品均於展覽期間展出，並於活動舞台舉行頒獎典禮。香港鐘表設計比賽多年來旨在進一步提高香港鐘表設計水平和品質，鼓勵新穎的創作意念，同時透過豐富展覽內容，以促進港製鐘表在本地及海外的銷路。今屆比賽設有公開組及學生組，分別以「難忘您」及「信自己」為題；「難忘您」冀望參賽者透過手表設計表達對難以忘懷的人之情感，「信自己」則以手表設計表達對實現目標的信心、克服困難的毅力，以及追逐夢想的勇氣。今年比賽反應熱烈，共收到116份參賽作品，而評審團由8位鐘表業代表，聯同嘉賓評審藝人張寶兒組成，合力選出兩組的冠、亞、季軍及優異獎。公開組作品顛覆傳統 設計玩味十足公開組冠軍為譚國棟設計的「定格」，由穎時錶業有限公司贊助，以相機鏡頭為設計主軸，把最精彩的兩面同時展現，包括於右邊視窗展示機芯運作，並於左邊視窗顯示時間，呈獻出顛覆傳統的佈局。這設計靈感源自設計師小時候父親替他拍照時，被照相機遮蓋了的半邊臉龐。亞軍為黃定邦設計的「小露保」，由浪西錶有限公司及寶暉精密有限公司贊助，以玩具機械人作為設計靈感，表達「成年人依舊可保留童真」。季軍作品「Backtrack」由達之訊時計有限公司設計，融入了「遊戲機」、「錄影帶」、「黑膠唱片」等元素，讓手表可透過更換不同的「遊戲帶」成為具玩味、Y2K風格的時尚配飾。學生組作品以鐘表設計反思成功要素學生組供香港註冊學校之「全日制學生」參與，透過比賽提拔富有設計天賦的後起之秀。冠軍作品「Aspire」由就讀香港知專設計學院的陳芷盈設計。手表上的珠子移動時，象徵胸懷勇氣與自信地追逐目標，而靜止時則象徵停步反思。亞軍得主為德望學校的李聿桐，作品「信望愛」在腕表外圈印有「愛」、「希望」和「信念」的字樣，帶出以上三個引領人們取得成功及克服困難的重要元素。季軍作品名為「漣漪中的殘星」，由香港知專設計學院的葉婉詩設計，表面帶有漣漪的紋路，並以星星作為時針，表達「即使生活如漣漪，但仍然充滿希望」。今年繼續設有「市場潛力大獎」，由8位資深鐘表製造商與香港貿發局時任助理總裁梁國浩組成評審團，攜手選出一件具市場潛力的學生組作品以作表揚。獎項再由同時獲得冠軍並就讀香港知專設計學院的陳芷盈奪得，香港表廠商會及香港鐘表業總會將把她的得獎設計「Aspire」付諸生產，並於香港貿發局「香港•設計廊」推出市場售賣。圖片下載：http://bit.ly/4n9MgRQ第42屆香港鐘表設計比賽公開組冠軍作品「定格」。第42屆香港鐘表設計比賽公開組亞軍作品「小露保」。第42屆香港鐘表設計比賽公開組季軍作品「Backtrack」。第42屆香港鐘表設計比賽學生組冠軍兼市場潛力大獎作品「Aspire」。第42屆香港鐘表設計比賽學生組亞軍作品「信望愛」。第42屆香港鐘表設計比賽學生組季軍作品「漣漪中的殘星」。第42屆香港鐘表設計比賽設有公開組及學生組進行比賽，由藝人張寶兒擔任嘉賓評判並出席頒獎典禮。相關網頁：香港鐘表展：hkwatchfair.hktdc.com/tc國際名表薈萃：hkwatchfair.hktdc.com/te/tc傳媒查詢新聞界如有查詢，請聯絡香港貿發局傳訊及公共事務部：徐俊逸 電話：(852) 2584 4395 電郵：johnny.cy.tsui@hktdc.org香港貿易發展局香港貿易發展局(香港貿發局)是於1966年成立的法定機構，負責促進、協助和發展香港貿易。香港貿發局在世界各地設有超過50個辦事處，其中13個設於中國內地，致力推廣本港作為雙向環球投資及商業樞紐。 香港貿發局通過舉辦國際展覽會、會議及商貿考察團，為企業(尤其是中小企)開拓內地和環球市場的機遇。香港貿發局亦通過研究報告和數碼資訊平台，提供最新的市場分析和產品資訊。有關香港貿發局的其他資訊，請瀏覽www.hktdc.com/aboutus/tc。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com